...
首页> 外文期刊>Nature chemical biology >Structural insights into the subtype-selective antagonist binding to the M-2 muscarinic receptor
【24h】

Structural insights into the subtype-selective antagonist binding to the M-2 muscarinic receptor

机译:亚型选择性拮抗剂与M-2毒蕈碱受体结合的结构见解

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Human muscarinic receptor M-2 is one of the five subtypes of muscarinic receptors belonging to the family of G-protein-coupled receptors. Muscarinic receptors are targets for multiple neurodegenerative diseases. The challenge has been designing subtype-selective ligands against one of the five muscarinic receptors. We report high-resolution structures of a thermostabilized mutant M-2 receptor bound to a subtype-selective antagonist AF-DX 384 and a nonselective antagonist NMS. The thermostabilizing mutation S110R in M-2 was predicted using a theoretical strategy previously developed in our group. Comparison of the crystal structures and pharmacological properties of the M-2 receptor shows that the Arg in the S110R mutant mimics the stabilizing role of the sodium cation, which is known to allosterically stabilize inactive state(s) of class A GPCRs. Molecular dynamics simulations reveal that tightening of the ligand-residue contacts in M-2 receptors compared to M-3 receptors leads to subtype selectivity of AF-DX 384.
机译:人毒蕈碱受体M-2是属于G蛋白偶联受体家族的肌肉蛋白受体的五种亚型之一。肌肉蛋白受体是多种神经变性疾病的靶标。挑战一直在设计针对五种毒蕈碱受体中的一种亚型选择性配体。我们向亚型选择性拮抗剂AF-DX 384和非选择性拮抗剂NMS报告与亚型选择性拮抗剂AF-DX 384结合的热稳定突变体M-2受体的高分辨率结构。使用先前在本组中开发的理论策略预测M-2中的热稳定突变S110R。 M-2受体的晶体结构和药理学性质的比较表明,S110R突变体中的Arg模仿钠阳离子的稳定作用,该阳离子是已知的,该稳定性地是稳定稳定的A类GPCR的无活性状态。分子动力学模拟表明,与M-3受体相比,M-2受体中的配体残基接触的接触导致AF-DX 384的亚型选择性。

著录项

  • 来源
    《Nature chemical biology》 |2018年第12期|共11页
  • 作者单位

    Kyoto Univ Dept Cell Biol &

    Med Chem Grad Sch Med Sakyo Ku Konoe Kyoto Japan;

    City Hope Natl Med Ctr Dept Mol Imaging &

    Therapy Beckman Res Inst Duarte CA USA;

    Stanford Univ Dept Mol &

    Cellular Physiol Sch Med Stanford CA USA;

    Chiba Univ Grad Sch Sci Inage Ku Chiba Japan;

    RIKEN SPring 8 Ctr Tokyo Hyogo Japan;

    RIKEN SPring 8 Ctr Tokyo Hyogo Japan;

    Kyoto Univ Dept Cell Biol &

    Med Chem Grad Sch Med Sakyo Ku Konoe Kyoto Japan;

    Kyoto Univ Dept Cell Biol &

    Med Chem Grad Sch Med Sakyo Ku Konoe Kyoto Japan;

    Kyoto Univ Dept Cell Biol &

    Med Chem Grad Sch Med Sakyo Ku Konoe Kyoto Japan;

    Chiba Univ Grad Sch Sci Inage Ku Chiba Japan;

    Kyoto Univ Inst Adv Energy Uji Kyoto Japan;

    RIKEN SPring 8 Ctr Tokyo Hyogo Japan;

    Stanford Univ Dept Mol &

    Cellular Physiol Sch Med Stanford CA USA;

    City Hope Natl Med Ctr Dept Mol Imaging &

    Therapy Beckman Res Inst Duarte CA USA;

    Japan Sci &

    Technol Agcy Res Accelerat Program Membrane Prot Crystallog Project Sakyo Ku Konoe Kyoto Japan;

    Kyoto Univ Dept Cell Biol &

    Med Chem Grad Sch Med Sakyo Ku Konoe Kyoto Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号